New Delhi, March 11 -- Healthcare stock Park Medi World (PARKHOSP) is poised to benefit from India's structural shortage of hospital beds, improving reimbursement dynamics and faster healthcare growth in Tier II markets, Nuvama said while initiating coverage.

With improving balance sheet quality and visible growth drivers, Nuvama has initiated coverage with a 'Buy' rating and a target price of Rs.280, indicating an upside potential of around 37%.

The company operates 14 multi-super-specialty hospitals with about 3,250 beds, including roughly 870 ICU beds, across Haryana, Punjab, Delhi and Rajasthan.

"With a visible expansion pipeline, bed capacity is seen rising to around 5,260 by FY28E," said the brokerage.

The brokerage informed tha...